Lifecore Biomedical, Inc. \De\ 8-K Filing
Ticker: LFCR · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1005286
| Field | Detail |
|---|---|
| Company | Lifecore Biomedical, Inc. \De\ (LFCR) |
| Form Type | 8-K |
| Filed Date | Nov 17, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Lifecore Biomedical, Inc. \De\ (ticker: LFCR) to the SEC on Nov 17, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ich registered Common stock, par value $0.001 per share LFCR The NASDAQ Global Select).
How long is this filing?
Lifecore Biomedical, Inc. \De\'s 8-K filing is 2 pages with approximately 526 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-11-17 16:10:55
Key Financial Figures
- $0.001 — ich registered Common stock, par value $0.001 per share LFCR The NASDAQ Global Select
Filing Documents
- lfcr-20251117.htm (8-K) — 24KB
- lifecoreinvestorpresenta.htm (EX-99.1) — 28KB
- lifecoreinvestorpresenta001.jpg (GRAPHIC) — 110KB
- lifecoreinvestorpresenta002.jpg (GRAPHIC) — 99KB
- lifecoreinvestorpresenta003.jpg (GRAPHIC) — 274KB
- lifecoreinvestorpresenta004.jpg (GRAPHIC) — 192KB
- lifecoreinvestorpresenta005.jpg (GRAPHIC) — 128KB
- lifecoreinvestorpresenta006.jpg (GRAPHIC) — 118KB
- lifecoreinvestorpresenta007.jpg (GRAPHIC) — 109KB
- lifecoreinvestorpresenta008.jpg (GRAPHIC) — 137KB
- lifecoreinvestorpresenta009.jpg (GRAPHIC) — 108KB
- lifecoreinvestorpresenta010.jpg (GRAPHIC) — 125KB
- lifecoreinvestorpresenta011.jpg (GRAPHIC) — 99KB
- lifecoreinvestorpresenta012.jpg (GRAPHIC) — 104KB
- lifecoreinvestorpresenta013.jpg (GRAPHIC) — 83KB
- lifecoreinvestorpresenta014.jpg (GRAPHIC) — 67KB
- lifecoreinvestorpresenta015.jpg (GRAPHIC) — 64KB
- lifecoreinvestorpresenta016.jpg (GRAPHIC) — 77KB
- lifecoreinvestorpresenta017.jpg (GRAPHIC) — 90KB
- lifecoreinvestorpresenta018.jpg (GRAPHIC) — 120KB
- lifecoreinvestorpresenta019.jpg (GRAPHIC) — 97KB
- lifecoreinvestorpresenta020.jpg (GRAPHIC) — 91KB
- lifecoreinvestorpresenta021.jpg (GRAPHIC) — 157KB
- lifecoreinvestorpresenta022.jpg (GRAPHIC) — 92KB
- 0001005286-25-000150.txt ( ) — 3678KB
- lfcr-20251117.xsd (EX-101.SCH) — 2KB
- lfcr-20251117_lab.xml (EX-101.LAB) — 21KB
- lfcr-20251117_pre.xml (EX-101.PRE) — 12KB
- lfcr-20251117_htm.xml (XML) — 3KB
01 Regulation FD
Item 7.01 Regulation FD. Beginning on November 18, 2025, Lifecore Biomedical, Inc. (the "Company") intends to use a presentation (the "Presentation") in discussions with certain of its investors, analysts and others. A copy of the Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this Item 7.01. A copy of the presentation will be furnished at, and posted on, the Company's website (https://ir.lifecore.com/events-presentations). The information furnished in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Lifecore Biomedical Presentation dated November 17, 2025 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 17, 2025 LIFECORE BIOMEDICAL, INC. By: /s/ Ryan D. Lake Ryan D. Lake Chief Financial Officer